Buy AnaptysBio Stock | ANAB Stock Price & Latest News | Public.com
ANAB

AnaptysBio

$0.00 (0.00%)Today
    View AnaptysBio (ANAB) stock trends here

    About ANAB

    AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermut...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    1.2
    0.51
    -0.18
    -0.87
    Q3 2020
    Q4 2020
    Q1 2021
    Q2 2021

    Expected EPS
    Q2 2021

    -$0.27

    Actual EPS
    Q2 2021

    Stats

    Market Cap$599,37M
    Volume137,27k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$35.85
    1 Year Low$13.92
    Open$21.74
    High$22.76
    Low$21.36

    Buy any stock with any amount of money.

    Download the App
    Download the app